担保管理规定 中核苏阀科技实业股份有限公司 担保管理规定 （经第九届董事会第三次会议审议通过，待提交2025年第五次临时股东会审议） 第一章 总 则 第一条 为规范中核苏阀科技实业股份有限公司（以下简称 "中核科技"或"公司"）担保行为，加强担保管理，防范经营风 险，制定本规定。 第二条 本办法适用于中核科技本部及下属子公司开展担保 工作，包括反担保。 第三条 本办法所称"担保"，是指按照《中华人民共和国民 法典》的规定，各单位在生产经营和项目建设过程中，为确保特定 的债权人实现债权，以债务人或第三人的信用或者特定财产来督促 债务人履行债务的行为。 第四条 担保类型及担保方式 按担保主体划分，分为用自身信用或特定财产等为自身债务提 供担保、集团公司内部具有股权关系的法人主体之间提供的担保。 按业务类别划分，分为融资类担保和履约类担保。其中融资类 担保指为取得融资而提供的各种形式的担保，如一般保证、连带责 任保证、抵押、质押等，也包括出具有担保效力的共同借款合同、 差额补足承诺、安慰承诺函、流动性支持、维好协议等支持性函件 - 1 - 担保管理规定 的隐性担保；履约担保指为履行特定合同中承诺的义务而提供的担 保 ...

股票代码: 000777 公司简称：中核科技 公告编号:2025—062 中核苏阀科技实业股份有限公司 关于选聘会计师事务所的公告 中 核 苏 本公司及董事会全体成员保证公告信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或者重大遗漏。 阀科技实业股份有限公司（以下简称"公司"）第九届董事会第三次全体会议于 2025 年 10 月 27 日在 公司会议室以现场和通讯相结合的方式召开，审议通过了《关于选聘会计师事务所的议案》。根据公司 第九届董事会审计委员会第三次会议提议，拟续聘信永中和会计师事务所（特殊普通合伙）（以下简称 "信永中和"）为公司 2025 年度审计机构，期限一年。本议案仍需提交公司股东会审议。公司现将此 次拟续聘会计师事务所的基本情况公告如下： 一、拟续聘会计师事务所的基本情况 1、 基本信息 机构名称：信永中和会计师事务所（特殊普通合伙） 成立日期：2012 年 3 月 2 日 组织形式：特殊普通合伙企业 注册地址：北京市东城区朝阳门北大街 8 号富华大厦 A 座 8 层 首席合伙人：谭小青先生 截至 2024 年 12 月 31 日，信永中和合伙人（股东）259 人，注册会计师 ...

1、股东会届次：2025 年第五次临时股东会 证券代码：000777 证券简称：中核科技 公告编号：2025-063 2、股东会的召集人：董事会 中核苏阀科技实业股份有限公司 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票上市规则》《深 圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等法律、行政法规、部门规章、 规范性文件及《公司章程》的有关规定。 关于召开公司 2025 年第五次临时股东会的通知 4、会议时间： 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 （1）现场会议时间：2025 年 11 月 14 日 15:00 一、召开会议的基本情况 5、会议的召开方式：现场表决与网络投票相结合。 6、会议的股权登记日：2025 年 11 月 07 日 7、出席对象： （1）在股权登记日持有公司股份的普通股股东或其代理人； 于股权登记日 2025 年 11 月 7 日（星期五）收市后在中国证券登记结算有限责任公司深圳分公司登 记在册的公司全体股东均有权出席本次股东会，并可以以书面形式委托代理人出席会议和参加表决，该 ...

股票代码: 000777 公司简称：中核科技 公告编号:2025-060 中核苏阀科技实业股份有限公司 第九届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 中核苏阀科技实业股份有限公司（以下简称"公司"）第九届董事会第三次会议于 2025 年 10 月 17 日以书面方式向全体董事发出会议通知，会议于 2025 年 10 月 27 日在公司会议 室以现场和通讯相结合的方式召开。 会议应参与表决董事 9 人，实际参与表决董事 9 人，其中：现场参与表决董事 8 人，通 讯参与表决董事 1 人，职工董事陈国辉先生以通讯形式参与表决。公司高管列席了本次董事 会。本次会议的召开符合《公司法》和《公司章程》的有关规定，会议合法有效。 会议内容如下： 一、审议并通过了关于《2025 年第三季度报告》的议案； 经审议，表决结果：同意9票，反对0票，弃权0票，回避0票 本议案已经第九届董事会审计委员会 2025 年第 3 次会议审议通过。 具体内容详见同日刊登于巨潮资讯网 www.cninfo.com.cn 的《2025 年第三季度报告》 公告编号 ...

Core Insights - The company reported a third-quarter revenue of 378 million yuan, representing a year-on-year decrease of 0.85% [1] - The net profit for the third quarter was 34.73 million yuan, down 13.47% year-on-year [1] - For the first three quarters, the total revenue reached 1.083 billion yuan, showing a year-on-year growth of 5.60% [1] - The net profit for the first three quarters was 112 million yuan, reflecting a year-on-year decline of 3.58% [1]

Financial Performance - The company's operating revenue for Q3 2025 was ¥378,392,227.01, a decrease of 0.85% compared to the same period last year[5] - Net profit attributable to shareholders was ¥34,739,273.05, down 13.47% year-on-year[5] - Basic earnings per share decreased by 10.00% to ¥0.09, while diluted earnings per share also fell by 10.00% to ¥0.09[5] - Total operating revenue for the current period reached ¥1,082,514,885.96, an increase of 5.0% compared to ¥1,025,090,350.53 in the previous period[20] - Net profit for the current period was ¥111,566,679.64, a decrease of 3.7% from ¥115,707,671.37 in the previous period[21] - Comprehensive income totalled ¥193,731,173.15, an increase of 79.2% compared to ¥108,318,296.82 in the previous period[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,703,429,444.12, reflecting a 1.17% increase from the end of the previous year[5] - Total current assets amount to ¥2,348,092,795.95, a decrease from ¥2,454,049,618.78 at the beginning of the period[16] - Total non-current assets increased to ¥1,355,336,648.17 from ¥1,206,649,915.70[17] - The total liabilities amounted to ¥1,415,679,389.28, a decrease of 5.8% from ¥1,502,247,450.30 in the previous period[18] - Total current liabilities decreased to ¥1,353,689,725.50 from ¥1,430,776,922.54[17] Cash Flow - Cash and cash equivalents decreased by 72.98% to ¥112,717,866.17, primarily due to increased payments for goods and taxes[9] - Cash flow from operating activities showed a net outflow of ¥303,476,512.47, an improvement from a net outflow of ¥343,301,925.16 in the previous period[23] - Cash inflow from investment activities totaled $1,406,021.25, while cash outflow amounted to $23,933,957.81, resulting in a net cash flow of -$22,527,936.56 from investment activities[24] - Cash inflow from financing activities was $251,902,000.00, with cash outflow of $226,996,171.09, leading to a net cash flow of $24,905,828.91 from financing activities[24] - The net increase in cash and cash equivalents was -$301,267,926.85, compared to -$122,809,671.40 in the previous period[24] - The ending balance of cash and cash equivalents was $108,256,099.79, down from $116,059,525.19 in the prior period[24] Shareholder Information - Total number of common shareholders at the end of the reporting period is 72,047[14] - The largest shareholder, China Nuclear Suzhou Valve Co., Ltd., holds 17.92% of shares, totaling 68,715,360 shares[14] - The second largest shareholder, China Nuclear Power Engineering Co., Ltd., holds 9.33% of shares, totaling 35,753,819 shares[14] Other Financial Metrics - The company reported a significant increase in accounts receivable financing, rising by 229.37% to ¥21,738,842.42 due to higher acceptance bills from banks[9] - Other income increased by 25.88% to ¥11,975,679.47, mainly due to additional VAT deductions related to advanced manufacturing[13] - The company recorded a decrease in financial expenses by 25.00% to ¥3,400,835.15, attributed to reduced exchange losses and interest expenses[13] - The total equity attributable to shareholders increased by 5.99% to ¥2,287,750,054.84 compared to the end of the previous year[5] - Total equity attributable to shareholders of the parent company increased to ¥2,287,750,054.84, up 6.0% from ¥2,158,452,084.18 in the previous period[18] - Research and development expenses increased to ¥40,451,825.11, up 16.5% from ¥34,626,814.74 in the previous period[20] - Investment income for the current period was ¥86,992,903.25, up 8.2% from ¥80,505,212.63 in the previous period[21] Accounting and Reporting - The third quarter financial report was not audited[25] - The company will implement new accounting standards starting in 2025[26]

Core Viewpoint - The coal chemical concept sector has shown a positive performance, with a 1.49% increase, ranking 10th among concept sectors, driven by significant gains in several stocks [1][2]. Group 1: Sector Performance - The coal chemical concept sector increased by 1.49%, with 79 stocks rising, including notable gainers such as Shaanxi Black Cat, Shanxi Coking Coal, and Yunmei Energy, which hit the daily limit [1][2]. - Major stocks in the sector saw significant increases, with Zhongke Technology, Hengli Petrochemical, and Aerospace Power rising by 6.35%, 5.83%, and 5.09% respectively [1]. - Conversely, stocks like Beiken Energy, Weili, and Huayi Group experienced declines, with drops of 2.74%, 2.43%, and 2.36% respectively [1]. Group 2: Capital Flow - The coal chemical concept sector attracted a net inflow of 786 million yuan, with 47 stocks receiving net inflows, and 7 stocks exceeding 100 million yuan in net inflow [2]. - Shanxi Coking Coal led the net inflow with 182 million yuan, followed by Shaanxi Black Cat, Shanxi Coal, and Meijin Energy with net inflows of 169 million yuan, 168 million yuan, and 133 million yuan respectively [2]. - The net inflow ratios for Shaanxi Black Cat, Yunmei Energy, and Shanxi Coking Coal were 44.11%, 40.88%, and 23.39% respectively, indicating strong investor interest [3].

Group 1 - The core point of the news is the recent performance of China Nuclear Technology, which saw a stock price increase of 5.14% to 21.68 CNY per share, with a trading volume of 617 million CNY and a turnover rate of 7.78%, leading to a total market capitalization of 8.312 billion CNY [1] - China Nuclear Technology has experienced a continuous stock price increase for three consecutive days, with a cumulative increase of 0.78% during this period [1] - The company, established on July 2, 1997, specializes in the research, design, manufacturing, and sales of industrial valves, with its main business revenue composition being 44.17% from nuclear power and nuclear chemical products, 29.26% from oil and petrochemical products, 22.16% from other valves, 3.22% from forgings and blanks, and 1.19% from other supplementary products [1] Group 2 - From the perspective of fund holdings, Ping An Fund has a significant position in China Nuclear Technology, with the Ping An CSI 2000 Enhanced Strategy ETF holding 3,600 shares, accounting for 0.28% of the fund's net value, ranking as the seventh largest holding [2] - The Ping An CSI 2000 Enhanced Strategy ETF, established on December 27, 2023, has a latest scale of 28.7267 million CNY and has achieved a year-to-date return of 26.25%, ranking 1853 out of 4218 in its category [2] - The fund manager, Li Yan, has been in charge for 1 year and 304 days, with the fund's total asset scale at 12.611 billion CNY, achieving a best return of 70% and a worst return of 14.52% during his tenure [2]

Core Viewpoint - The report highlights that China Nuclear Technology (000777) is experiencing steady revenue growth driven by its nuclear power valve business, accelerated domestic production, and overseas expansion [1][2]. Financial Performance - In the first half of 2025, the company achieved operating revenue of 704 million yuan, a year-on-year increase of 9.43%, and a net profit attributable to shareholders of 77 million yuan, up 1.68% year-on-year [2][3]. - The nuclear power and nuclear chemical valve segment generated revenue of 311 million yuan, a significant year-on-year increase of 26.54%, contributing 46.57% to gross profit [3]. Business Segments - The oil and petrochemical valve segment reported revenue of 206 million yuan, a year-on-year increase of 13.92%, with a gross profit margin of 29.55% [3]. - Other valve revenues declined by 16.25%, indicating intensified competition in the traditional industrial valve sector [3]. Cost Management - The company’s expense ratio for the first half of 2025 was 17.22%, a decrease of 1.18 percentage points year-on-year [4]. - Research and development investment increased to 28 million yuan, up 7.24% year-on-year, focusing on key equipment like ultra-large nuclear power valves [4]. Market Strategy - The domestic replacement and high-end development of nuclear power valves are central to the company's strategy, supported by policy initiatives [5]. - The company is expanding into overseas markets and enhancing operational services to capture additional market share [5][6]. Long-term Outlook - The company is expected to benefit from its integrated capabilities in forging, processing, assembly, and service, with a projected net profit of 267 million yuan, 307 million yuan, and 350 million yuan for 2025-2027 [6]. - The estimated earnings per share for the same period are projected to be 0.70, 0.80, and 0.91 yuan, with corresponding PE ratios of 30.31, 26.34, and 23.09 [6].

Investment Rating - The report assigns a "Buy" rating to the company, indicating an expected stock price increase of over 15% compared to the benchmark index [7]. Core Insights - The company's revenue for the first half of 2025 reached 704 million, representing a year-on-year growth of 9.43%. The net profit attributable to shareholders was 77 million, with a growth of 1.68% year-on-year [1][2]. - The nuclear power business is a strong driver of revenue growth, with significant contributions from high-end valve products such as the "Hualong One" pressure relief valve and CAP1400 main steam isolation valve, which saw a revenue increase of 26.54% [2]. - The company is actively expanding into new application scenarios, achieving breakthroughs in emerging fields like POE (polyolefin elastomer) and pumped storage, while also enhancing its service capabilities across the entire valve lifecycle [2][4]. Summary by Sections Financial Performance - In the first half of 2025, the company reported a revenue of 704 million, with a 9.43% increase year-on-year. The nuclear and nuclear chemical valve business generated 311 million, up 26.54%, contributing 46.57% to gross profit [1][2]. - The gross margin for the first half of 2025 was 19.56%, down 4.88 percentage points year-on-year, primarily due to a 48.06% increase in costs for the nuclear valve business [3]. Cost Management - The company managed to reduce its selling expenses to 23 million, a decrease of 28.64% year-on-year, while financial expenses dropped to 1 million, down 33.44% [3]. - Research and development expenses increased to 28 million, up 7.24% year-on-year, focusing on key equipment like ultra-large diameter nuclear valves [3]. Strategic Initiatives - The company is accelerating domestic substitution and high-end development of nuclear valves, supported by policies that enhance its supply capabilities across various reactor generations [4]. - The strategic focus includes innovation and return on investment, with plans to upgrade smart manufacturing capacities and extend operational services through overseas expansions [4][5]. Profit Forecast - The company is expected to see net profits of 267 million, 307 million, and 350 million for 2025, 2026, and 2027 respectively, with corresponding earnings per share of 0.70, 0.80, and 0.91 [5][10].